ClinicalTrials.Veeva

Menu

The Effect of Dexmedetomidine on Decreasing Emergence Agitation and Delirium in Pediatric Patients Undergoing Strabismus Surgery

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Strabismus

Treatments

Drug: placebo group
Drug: Dexmedetomidine

Study type

Interventional

Funder types

Other

Identifiers

NCT01512355
4-2011-0466

Details and patient eligibility

About

Postoperative agitation in children is a well-documented clinical phenomenon with incidence ranging from 10% to 67%. Recently, dexmedetomidine has been investigated extensively in the pediatric population and there is now increasing evidence to support the use of this drug as sedative and anesthetic adjunct in children. The purpose of this study is to determine whether prophylactic use of intraoperative dexmedetomidine to prevent of emergence delirium.

Enrollment

88 patients

Sex

All

Ages

Under 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • the patient undergoing the strabismus surgery in severance hospital

Exclusion criteria

  • delayed development
  • mental retardation
  • cerebral palsy
  • preoperative EKG abnormality e.g. cardiovascular conduction disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

88 participants in 2 patient groups, including a placebo group

dexmedetomidine
Experimental group
Treatment:
Drug: Dexmedetomidine
placebo
Placebo Comparator group
Treatment:
Drug: placebo group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems